BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19699016)

  • 21. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA; Rajkumar SV
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1093-113, ix. PubMed ID: 17996590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The incidental monoclonal protein: current approach to management of monoclonal gammopathy of undetermined significance (MGUS).
    Madan S; Greipp PR
    Blood Rev; 2009 Nov; 23(6):257-65. PubMed ID: 19699016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal gammopathy of undetermined significance.
    Kyle RA; Rajkumar SV
    Br J Haematol; 2006 Sep; 134(6):573-89. PubMed ID: 16938117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.
    Kyle RA; Rajkumar SV
    Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
    Stelmach-Gołdyś A; Czarkowska-Paczek B
    Przegl Lek; 2012; 69(5):194-6. PubMed ID: 23050415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal gammopathies of undetermined significance.
    Kyle RA; Rajkumar SV
    Best Pract Res Clin Haematol; 2005; 18(4):689-707. PubMed ID: 16026745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Monoclonal gammopathies of undetermined significance].
    Krizalkovicová V; Maisnar V; Pour L; Radocha J; Hájek R
    Klin Onkol; 2008; 21(4):160-4. PubMed ID: 19102222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Rajkumar SV; Lacy MQ; Kyle RA
    Blood Rev; 2007 Sep; 21(5):255-65. PubMed ID: 17367905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Monoclonal gammopathy of undetermined significance].
    Chaïbi P; Merlin L; Thomas C; Piette F
    Ann Med Interne (Paris); 2002 Nov; 153(7):459-66. PubMed ID: 12598832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging concepts in monoclonal gammopathy of undetermined significance.
    Freytes CO
    Bol Asoc Med P R; 2010; 102(4):43-6. PubMed ID: 21766546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
    Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal gammopathy of undeterminated significance: introduction and current clinical issues.
    Klincová M; Sandecká V; Mikuláiová A; Radocha J; Maisnar V; Hájek R
    Klin Onkol; 2011; 24 Suppl():S14-7. PubMed ID: 21923058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal gammopathy of undetermined significance: a consensus statement.
    Berenson JR; Anderson KC; Audell RA; Boccia RV; Coleman M; Dimopoulos MA; Drake MT; Fonseca R; Harousseau JL; Joshua D; Lonial S; Niesvizky R; Palumbo A; Roodman GD; San-Miguel JF; Singhal S; Weber DM; Zangari M; Wirtschafter E; Yellin O; Kyle RA
    Br J Haematol; 2010 Jul; 150(1):28-38. PubMed ID: 20507313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis and progression of monoclonal gammopathy of undetermined significance.
    Bladé J; Rosiñol L; Cibeira MT; de Larrea CF
    Leukemia; 2008 Sep; 22(9):1651-7. PubMed ID: 18668131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
    Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Waldenström macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition.
    McMaster ML; Caporaso N
    Br J Haematol; 2007 Dec; 139(5):663-71. PubMed ID: 18021080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What is the significance of monoclonal gammopathy of undetermined significance?
    Atkin C; Richter A; Sapey E
    Clin Med (Lond); 2018 Oct; 18(5):391-396. PubMed ID: 30287433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).
    Kyle RA; Rajkumar SV
    Oncology (Williston Park); 2011 Jun; 25(7):578-86. PubMed ID: 21888255
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.